Related Experiment Video
Updated: Jun 17, 2026

Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle (GUV) Membranes
Published on: July 28, 2016
Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts
Takayuki Nitta1, Yurii Kuznetsov, Alexander McPherson
1Department of Molecular Biology and Biochemistry, and Cancer Research Institute, University of California, Irvine, CA 92697-3905, USA.
Abstract:
Murine leukemia viruses encode a unique form of Gag polyprotein, gPr80gag or glyco-gag. Translation of this protein is initiated from full-length viral mRNA at an upstream initiation site in the same reading frame as Pr65(gag), the precursor for internal structural (Gag) proteins. Whereas gPr80gag is evolutionarily conserved among gammaretroviruses, its mechanism of action has been unclear, although it facilitates virus production at a late assembly or release step. Here, it is shown that gPr80gag facilitates release of Moloney murine leukemia virus (M-MuLV) from cells along an IFN-sensitive pathway. In particular, gPr80gag-facilitated release occurs through lipid rafts, because gPr80gag-negative M-MuLV has a lower cholesterol content, is less sensitive to inhibition of release by the cholesterol-depleting agent MbetaCD, and there is less Pr65gag associated with detergent-resistant membranes in mutant-infected cells. gPr80gag can also facilitate the release of HIV-1-based vector particles from human 293T cells.
Insights
Murine leukemia viruses
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Murine leukemia viruses possess a unique glyco-gag protein (gPr80gag).
- The precise function of gPr80gag in viral production has remained largely unknown.
- gPr80gag is conserved across gammaretroviruses and implicated in late viral assembly or release steps.
Purpose of the Study:
- To elucidate the mechanism by which gPr80gag facilitates murine leukemia virus release.
- To investigate the role of lipid rafts in gPr80gag-mediated viral release.
- To determine if gPr80gag can enhance the release of heterologous viral vectors.
Main Methods:
- Analysis of Moloney murine leukemia virus (M-MuLV) release in gPr80gag-expressing and deficient cells.
- Assessment of viral particle cholesterol content and sensitivity to MbetaCD.
- Quantification of Pr65gag association with detergent-resistant membranes.
- Evaluation of HIV-1-based vector release from 293T cells.
Main Results:
- gPr80gag significantly facilitates M-MuLV release via an interferon-sensitive pathway.
- gPr80gag-dependent release involves lipid rafts, evidenced by altered cholesterol content and MbetaCD sensitivity.
- Absence of gPr80gag reduces Pr65gag association with detergent-resistant membranes.
- gPr80gag enhances the release of HIV-1-based vector particles.
Conclusions:
- gPr80gag plays a critical role in the efficient release of murine leukemia viruses.
- Lipid raft-mediated mechanisms are essential for gPr80gag-facilitated viral release.
- gPr80gag has potential applications in enhancing the production of lentiviral vectors.
Related Concept Videos
Inhibitors Of Virion Release
Rabies
Inhibitors of Virion Maturation and Assembly
Leaky Scanning
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Inhibitors of Viral Protein Synthesis

